Stein SM - Search Results

1

Randomised phase II trial (SWOG S1310) of single agent MEK inhibitor trametinib Versus 5-fluorouracil or capecitabine in refractory advanced biliary cancer.

Kim RD, McDonough S, El-Khoueiry AB, Bekaii-Saab TS, Stein SM, Sahai V, Keogh GP, Kim EJ, Baron AD, Siegel AB, Barzi A, Guthrie KA, Javle M, Hochster H. Kim RD, et al. Among authors: stein sm. Eur J Cancer. 2020 May;130:219-227. doi: 10.1016/j.ejca.2020.01.026. Epub 2020 Mar 29. Eur J Cancer. 2020. PMID: 32234665 Free PMC article. Clinical Trial.

2

Treatment paradigms with epidermal growth factor receptor-targeted therapies in colorectal cancer.

Stein S, Cohen DJ, Hochster HS. Stein S, et al. Clin Colorectal Cancer. 2010 Jun;9 Suppl 1:S44-50. doi: 10.3816/CCC.2010.s.006. Clin Colorectal Cancer. 2010. PMID: 20630850 Review.

3

FOLFIRINOX for locally advanced and metastatic pancreatic cancer: single institution retrospective review of efficacy and toxicity.

Gunturu KS, Yao X, Cong X, Thumar JR, Hochster HS, Stein SM, Lacy J. Gunturu KS, et al. Among authors: stein sm. Med Oncol. 2013 Mar;30(1):361. doi: 10.1007/s12032-012-0361-2. Epub 2012 Dec 28. Med Oncol. 2013. PMID: 23271209 Review.

4

A phase 2 study of oxaliplatin combined with continuous infusion topotecan for patients with previously treated ovarian cancer.

Stein SM, Tiersten A, Hochster HS, Blank SV, Pothuri B, Curtin J, Shapira I, Levinson B, Ivy P, Joseph B, Guddati AK, Muggia F. Stein SM, et al. Int J Gynecol Cancer. 2013 Nov;23(9):1577-82. doi: 10.1097/IGC.0b013e3182a809e0. Int J Gynecol Cancer. 2013. PMID: 24172094 Free PMC article. Clinical Trial.

5

Phase II Study of Modified FOLFOX6 With Bevacizumab in Metastatic Gastroesophageal Adenocarcinoma.

Li J, Yao X, Kortmansky JS, Fischbach NA, Stein S, Deng Y, Zhang Y, Doddamane I, Karimeddini D, Hochster HS, Lacy J. Li J, et al. Am J Clin Oncol. 2017 Apr;40(2):146-151. doi: 10.1097/COC.0000000000000114. Am J Clin Oncol. 2017. PMID: 25144267 Clinical Trial.

6

Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial.

Zhu AX, Park JO, Ryoo BY, Yen CJ, Poon R, Pastorelli D, Blanc JF, Chung HC, Baron AD, Pfiffer TE, Okusaka T, Kubackova K, Trojan J, Sastre J, Chau I, Chang SC, Abada PB, Yang L, Schwartz JD, Kudo M; REACH Trial Investigators. Zhu AX, et al. Lancet Oncol. 2015 Jul;16(7):859-70. doi: 10.1016/S1470-2045(15)00050-9. Epub 2015 Jun 18. Lancet Oncol. 2015. PMID: 26095784 Clinical Trial.

7

Gemcitabine plus nab-paclitaxel for advanced pancreatic cancer after first-line FOLFIRINOX: single institution retrospective review of efficacy and toxicity.

Zhang Y, Hochster H, Stein S, Lacy J. Zhang Y, et al. Exp Hematol Oncol. 2015 Oct 7;4:29. doi: 10.1186/s40164-015-0025-y. eCollection 2015. Exp Hematol Oncol. 2015. PMID: 26451276 Free PMC article.

8

Final analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer.

Stein SM, James ES, Deng Y, Cong X, Kortmansky JS, Li J, Staugaard C, Indukala D, Boustani AM, Patel V, Cha CH, Salem RR, Chang B, Hochster HS, Lacy J. Stein SM, et al. Br J Cancer. 2016 Mar 29;114(7):737-43. doi: 10.1038/bjc.2016.45. Br J Cancer. 2016. PMID: 27022826 Free PMC article. Clinical Trial.

9

Phase I study combining the aurora kinase a inhibitor alisertib with mFOLFOX in gastrointestinal cancer.

Goff LW, Azad NS, Stein S, Whisenant JG, Koyama T, Vaishampayan U, Hochster H, Connolly R, Weise A, LoRusso PM, Salaria SN, El-Rifai W, Berlin JD. Goff LW, et al. Invest New Drugs. 2019 Apr;37(2):315-322. doi: 10.1007/s10637-018-0663-0. Epub 2018 Sep 6. Invest New Drugs. 2019. PMID: 30191522 Free PMC article. Clinical Trial.

10

Genomic mutations and histopathologic biomarkers in Y⁹⁰ radioembolization for chemorefractory colorectal liver metastases.

Dendy MS, Ludwig JM, Kokabi N, Stein SM, Lacy J, Hochster HS, Kim HS. Dendy MS, et al. Among authors: stein sm. Oncotarget. 2018 Aug 21;9(65):32523-32533. doi: 10.18632/oncotarget.25992. eCollection 2018 Aug 21. Oncotarget. 2018. PMID: 30197760 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

104 results

Search Page